High intensity focused ultrasound (HIFU) is a novel prostate cancer treatment that minimizes side effect while destroying ...

When most men think about their prostate, it's to worry about whether they have prostate cancer or not. But another condition ...

Tissue-based genomic classifier tests, developed to improve prostate cancer risk assessment and treatment recommendations, ...

In 2023 alone, 288,300 new cases of prostate cancer will be diagnosed in the United States, according to the American Cancer ...

White button mushrooms promoted antitumor activity among men with prostate cancer, according to results of an ongoing randomized phase 2 trial.Treatment with white button mushroom tablets reduced ...

Alan Powell, 66, was diagnosed with prostate cancer in 2020 after a joke made him think about his health, and his brother ...

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.

Physicians in the field of urology have advised men, particularly those of African descent to stop attributing the cause of ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...

OncoAssure Ltd, an Irish medical diagnostic company, today announced the publication of new data, in the British Journal of Urology International Compass (BJUI Compass), which demonstrates the ...